The current state of medical therapy for cognitive decline and dementia is focused on single drug therapy. This approach has yielded unsatisfactory outcomes. A Functional Medicine approach utilizes a model of evaluation and therapeutics that is an assessment of the bioterrain of the unique individual in relation their individual genetics interaction with their environmental exposome to assess and provide a personalized, precision approach to brain health based on each individual’s genetics, the unique epigenetic triggers, the exacerbating hormone and nutritional imbalances as well as the deficiencies in optimal assimilation and biotransformation. Potential hormone imbalances, nutrient deficiencies combined with unique toxic insults may potentiate these processes leading to poor cognitive outcomes.

Content Access

Presented by: Lorraine Gahles-Kildow, PhD and Nancy Gahles DC, CCH, MBSR

Stress in the healthcare profession has reached epidemic proportions. Physician burnout is on the rise. Almost half of doctors experience at least one symptom of burnout and one third of intensive care unit nurses suffer from severe Burnout Syndrome (BOS) associated with stress. Caregivers, professional and those in family situations caring for parents, partners, and special needs children, often suffer undiagnosed BOS from stress.

Content Access

The Emerging Role of Applied Metabolomics

Content Access

Presented by: Tereza Hubkov, MD

As pharmaceuticals continue to be disappointing when it comes to prevention or treatment of dementia, or they are plagued with significant side effects, it is time to return to the many natural treatments used by our ancestors for many centuries and now increasingly more validated by modern research. Adaptogenic, nootropic plants, mushrooms, foods and culinary spices have shown significant ability to minimize the pathology of Alzheimer’s dementia, Parkinson’s disease, and other brain health disorders. In this session, participants will learn about the health benefits and safety of Ashwagandha, Reishi, Rhodiola, Schizandra, Lion’s mane, Bacopa, turmeric, garlic, sage, and cinnamon, to name just a few of nature’s broad apothecary.

Content Access

In 1996, the question originated from Dr. Eli A Friedman’s article, “can the Bowel act as a kidney substitute in advance renal failure?” prior to the discovery of the gut microbiome. The bowel was recognized as an organ in 2004 in Proceedings of the National Academy of Science. Advances in bioinformatics led to further understanding of the human gut microbiome. Exponential advances in technology led to a greater knowledge and understanding of the gut microbiomes’ role in health, and disease. The knowledge gained, lead to further understanding of the term dysbiosis (an imbalance of pathogenic gut bacteria). Now, dysbiosis is universally documented as the prime cause for various diseases. The connection between the gut and CKD became evident with the cover article in the Sept/2012 issue of Kidney International. Followed by, the publication of a similar article in Clinical Kidney Journal in 2015. In 1997 Enteric Dialysis® was transformed from a concept into a reality, by Dr. Ranganathan and his research team at Kibow Biotech Inc. After 20 years of R&D, Kibow has used clinical findings of pro/prebiotics to modulate the gut microbiome to improve clinical outcomes in CKD patients worldwide.

Content Access

Culinary Herbs & Spices as Food and Medicine

Content Access

Presented by: David Bouley; Carl Germano, CNS, CDN; Marc Grossman, OD, LAc; Mimi Guarneri, MD, FACC, ABOIM; David Perlmutter, MD, FACN, ABIHM; and Robert Silverman, DC, DACBN, DCBCN, MS, CCN, CNS, CSCS, CIISN, CKTP 

As practitioners, we all have different approaches to achieving optimal health, but we have a commonality in the human body. This panel of well-known experts will discuss how the silo walls of specialization can be broken down. To provide effective treatment, practitioners must see patients as the whole human body, not as cases involving only a single system. The panel will share their current thinking about how they see the human body holistically and how they search for root causes and resolutions to achieve better outcomes. This discussion will demonstrate how to get past the perceptual limits of silos and specialties and see patients as individuals, not cases.

Content Access

Presented by: Yehuda Shoenfeld, MD, FRCP, MAACR

Autoimmune diseases are conditions in which the immune system damages normal components of the individual. Thus, autoantibodies productions were found to be multifactorial in their etiology. For practical reasons these factors are classified into four categories: genetic, immune deficiencies, hormonal state, and environmental causes.

Content Access

LIMITED-TIME BUNDLE: Become an Integrative Practitioner member, and receive the Integrative Approaches to Pain Management for FREE (a $125 savings).

DETAILS --

Integrative Practitioner Membership

Access all Integrative Practitioner content -- unrestricted.

Memberships will automatically renew on an annual basis until cancelled. By becoming a member, you will be subscribed to the Integrative Practitioner Update, Integrative Practitioner's digital newsletter. You can unsubscribe at any time.

Integrative Approaches to Pain Management

Pain is one of the leading reasons why Americans turn to complementary and alternative therapies and practices, and the integrative healthcare community has been a tremendous player in ensuring non-pharmacologic approaches to pain management are readily available and included in national healthcare legislation and research initiatives. 

Bundle

This issue highlights advances in integrative healthcare practice, including new discoveries and collaborations across medical fields. 

Content Access